Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-06-19
1998-11-24
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544373, 548494, 548500, A61K 31495, C07D40306, C07D20920, C07D20924
Patent
active
058407260
ABSTRACT:
The present invention relates to substituted piperazinone derivatives (compounds of formula (1)) or stereoisomers, or pharmaceutically acceptable salts thereof and their use as tachykinin receptor antagonists. Such antagonists are useful in the treatment of tachykinin-mediated diseases and conditions disclosed herein including: asthma, cough, and bronchitis. The present invention also relates to intermediates useful in the preparation of compounds of formula (1).
REFERENCES:
patent: 4598079 (1986-07-01), Beyerle
patent: 5236921 (1993-08-01), Emonds-Alt
patent: 5317020 (1994-05-01), Emonds-Alt
Kitanaelwal et al, Chemical Abstracts, vol. 113, No. 78332 (1990).
Lewis et al, J. Med. Chem 38, pp. 923-933 (Mar. 17, 1995).
Roussi et al, Biochemical and Biophysical Research Communications, 176, pp. 894-901 (1991).
Maggi et al, J. Auton. Pharmacol. 13, pp. 23-93 (1993).
J. DiMaio, et al., "Synthesis of Chiral Piperazin-2-ones as Model Peptidomimetics", J. Chem. Soc. Perkin Trans, 1989.
Roubini, et al., "1,4-Piperazine-derived, partially nonpeptidic analogs of Substance P", Hebrew University of Jerusalem, 161-162.
Hagiwara, et al., Studies on Neurokinin Antagonists 3., J. Med. Chem. 36, 2266-2278, 1993.
Somers, et al., J. Med. Chem. 7:784-89 (1964).
Takase, et al., Tetrahedron, 42(21), 5887-5894, 1986.
Takase, et al, Tetrahedron Lett., 26(7), 847-850, 1985.
Kitandelwal et al, Chemical Abstracts, vol. 113, No. 78332 (1990).
Lewis et al, J. Med. Chem. 38, pp. 923-933 (Mar. 17, 1995).
Burkholder Timothy P.
Kudlacz Elizabeth M.
Le Tieu-Binh
Bernhardt Emily
Hoechst Marion Roussel Inc.
Stemerick David M.
LandOfFree
Heterocyclic substituted piperazinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted piperazinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted piperazinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702495